Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.718
+0.008 (1.06%)
At close: Jun 26, 2026, 4:00 PM EDT
0.730
+0.013 (1.74%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Tenaya Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Tenaya Therapeutics stock have an average target of 10.33, with a low estimate of 2.00 and a high estimate of 40. The average target predicts an increase of 1,339.72% from the current stock price of 0.72.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Tenaya Therapeutics stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 6 | 6 | 6 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 7 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $2 | Buy | Reiterates | $2 | +178.75% | Jun 4, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 3, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $4 | Buy | Maintains | $4 | +457.49% | Jun 3, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $3 | Buy | Maintains | $3 | +318.12% | Jun 3, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $5 | Buy | Maintains | $5 | +596.86% | May 18, 2026 |
Financial Forecast
Revenue This Year
8.51M
Revenue Next Year
n/a
from 8.51M
Decreased by -100.00%
EPS This Year
-0.38
from -0.59
EPS Next Year
-0.41
from -0.38
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.2M | n/a | |
| Avg | 8.5M | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | -100.0% | - |
| Avg | -100.0% | - |
| Low | -100.0% | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.27 | -0.29 | |
| Avg | -0.38 | -0.41 | |
| Low | -0.59 | -0.59 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.